$KARD
Kardigan, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$14.02
▼-10.12%-$1.58Market open
Kardigan, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $12.33 at 09:32 AM on Oct 07, then ran to $14.19 +15% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is KARD down today? It is at $14.02 (-9.93%), and our scanner flagged it 106 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment KARD spikes, and full due diligence on KARD — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $KARD 106 times in the last 30 days. Create a free account to track $KARD, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on KARD from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystKardigan Announces Appointment of Kristin Reinke, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Oct 1, 2026 · 34 days agoAcross every filing on file, supply equal to 10.3% of the tradeable float is in play - 10.3% more can still be issued.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
3,750,000 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $700.0M in size · Priced at $16/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Arch Venture Partners Xiii, Llc Director | Bought (open market) | +1.25M 1.3% of company | added 9.1% | 15.04M | $20.0M at $16.00 | Jun 22, 26 |
Berns Paul L Director | Bought (open market) | +1.25M 1.3% of company | added 9.1% | 15.04M | $20.0M at $16.00 | Jun 22, 26 |
Hrtg Gpe, Llc Beneficial Owner (10%) | Bought (open market) | +3.13M 3.3% of company | added 23% | 16.92M | $50.0M at $16.00 | Jun 22, 26 |
Edelberg Jay Officer | Acquired (grant/award) | +145K 0.2% of company | added 100% | 183K | n/a | Jun 17, 26 |
Giordano Douglas E. Director | Acquired (grant/award) | +21K 0.02% of company | n/a | 21K | n/a | Jun 17, 26 |
Walbert Timothy P Director | Acquired (grant/award) | +21K 0.02% of company | n/a | 21K | n/a | Jun 17, 26 |
Gianakakos Anastasios Officer | Acquired (grant/award) | +568K 0.6% of company | added 6.2% | 9.76M | n/a | Jun 17, 26 |
Popovits Kimberly J Director | Acquired (grant/award) | +21K 0.02% of company | n/a | 21K | n/a | Jun 17, 26 |
Jahn Brianne Officer | Acquired (grant/award) | +80K 0.09% of company | n/a | 80K | n/a | Jun 17, 26 |
Moriarty John B Officer | Acquired (grant/award) | +48K 0.05% of company | n/a | 48K | n/a | Jun 17, 26 |
Berns Paul L Director | Acquired (grant/award) | +13.79M 14.8% of company | n/a | 13.79M | n/a | Jun 17, 26 |
Berns Paul L Director | Acquired (grant/award) | +21K 0.02% of company | n/a | 21K | n/a | Jun 17, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on KARD from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
KARD last traded at $14.02, down 9.93% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Kardigan, Inc. Common Stock (KARD) is next expected to report earnings on Tuesday, November 10, 2026, about 5 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The KARD Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged KARD 106 times in the last 30 days.
KARD (Kardigan, Inc. Common Stock) trades on XNAS, with a market cap of about $1.45B in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge KARD for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$KARD discussion
Sign in to ask a question or join the discussion.